VKTX Viking Therapeutics, Inc.
Viking Therapeutics, Inc. (VKTX) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $4.9M.
Where they traded
Last open-market purchase: March 10, 2026 , by Aubuchon Neil William .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Lian Brian | President & CEO | Sell | 148,517 | $33.32 | $4.9M | 2,572,441 −5.5% of holding | |
| ZANTE GREG | Chief Financial Officer | Sell | 21,217 | $33.47 | $710.1K | 212,204 −9.1% of holding | |
| Mancini Marianna | Chief Operating Officer | Sell | 18,217 | $33.47 | $609.6K | 422,760 −4.1% of holding | |
| Aubuchon Neil William | Chief Commercial Officer | Buy | 4,475 | $33.50 | $149.9K | 4,475 | |
| Lian Brian 4 fills | President & CEO | Sell | 233,409 | $32.96 | $7.7M | 2,600,246 −8.2% of holding | |
| Mancini Marianna 4 fills | Chief Operating Officer | Sell | 57,661 | $32.98 | $1.9M | 434,890 −11.7% of holding | |
| ZANTE GREG 4 fills | Chief Financial Officer | Sell | 57,661 | $32.90 | $1.9M | 215,571 −21.1% of holding | |
| FOEHR MATTHEW W | Director | Sell | 16,000 | $35.11 | $561.7K | 132,036 −10.8% of holding | |
| Lian Brian | President & CEO | Sell | 38,989 | $35.01 | $1.4M | 2,419,109 −1.6% of holding | |
| Mancini Marianna | Chief Operating Officer | Sell | 6,185 | $35.00 | $216.5K | 382,467 −1.6% of holding | |
| ZANTE GREG | Chief Financial Officer | Sell | 6,185 | $35.00 | $216.5K | 173,592 −3.4% of holding | |
| Rowland Charles A Jr | Director | Sell | 60,000 | $35.57 | $2.1M | 30,000 −66.7% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.